Total Payments
$7,756
2024 Payments
$1,346
Companies
24
Transactions
377
Medicare Patients
1,902
Medicare Billing
$576,244
Payment Breakdown by Category
Food & Beverage$7,652 (98.7%)
Education$104.17 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,652 | 374 | 98.7% |
| Education | $104.17 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,508 | 120 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $596.83 | 33 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $591.89 | 31 | $0 (2024) |
| Lundbeck LLC | $462.03 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $382.80 | 17 | $0 (2024) |
| ITI, Inc. | $378.57 | 19 | $0 (2023) |
| Bausch Health US, LLC | $372.74 | 19 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $370.47 | 18 | $0 (2024) |
| Alkermes, Inc. | $344.03 | 16 | $0 (2024) |
| Neuronetics, Inc. | $342.51 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,346 | 61 | Otsuka America Pharmaceutical, Inc. ($212.60) |
| 2023 | $2,408 | 105 | AbbVie Inc. ($1,068) |
| 2022 | $1,642 | 79 | ABBVIE INC. ($567.85) |
| 2021 | $1,547 | 85 | AbbVie Inc. ($729.31) |
| 2020 | $442.93 | 27 | Allergan, Inc. ($227.96) |
| 2019 | $212.34 | 12 | Neuronetics, Inc. ($59.67) |
| 2018 | $105.05 | 5 | ARBOR PHARMACEUTICALS, INC. ($30.13) |
| 2017 | $53.43 | 3 | Shire North American Group Inc ($19.00) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: CNS | ||||||
| 11/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Neuropsychiatry | ||||||
| 10/31/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/31/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/30/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Neuropsychiatry | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $27.60 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: ANTI-ANXIETY | ||||||
| 09/18/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: CNS | ||||||
| 09/17/2024 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $26.82 | General |
| Category: PSYCHIATRY | ||||||
| 09/16/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/12/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: PSYCHIATRY | ||||||
| 08/07/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: ANTI-ANXIETY | ||||||
| 07/24/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 424 | 1,921 | $699,756 | $134,332 |
| 2022 | 5 | 422 | 1,774 | $401,900 | $115,938 |
| 2021 | 8 | 502 | 2,010 | $548,410 | $152,030 |
| 2020 | 9 | 554 | 2,397 | $611,370 | $173,945 |
Total Patients
1,902
Total Services
8,102
Medicare Billing
$576,244
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 486 | $140,722 | $42,015 | 29.9% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 12 | 407 | $381,470 | $38,849 | 10.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 128 | 554 | $84,232 | $27,989 | 33.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 307 | $58,449 | $18,160 | 31.1% |
| 90853 | Group psychotherapy | Office | 2023 | 20 | 142 | $9,882 | $3,005 | 30.4% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2023 | 12 | 13 | $13,000 | $2,360 | 18.2% |
| 90869 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent motor threshold redetermination with delivery and management | Office | 2023 | 11 | 12 | $12,000 | $1,954 | 16.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 367 | $91,750 | $31,010 | 33.8% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 11 | 311 | $186,600 | $30,386 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 146 | 458 | $77,860 | $26,332 | 33.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 132 | 535 | $37,450 | $26,192 | 69.9% |
| 90853 | Group psychotherapy | Office | 2022 | 15 | 103 | $8,240 | $2,018 | 24.5% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 16 | 492 | $295,200 | $49,042 | 16.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 130 | 428 | $107,000 | $39,474 | 36.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 155 | 461 | $78,370 | $28,964 | 37.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 144 | 525 | $36,750 | $26,958 | 73.4% |
| 90867 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), initial delivery and management | Office | 2021 | 14 | 15 | $15,000 | $2,705 | 18.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 15 | 15 | $5,850 | $2,192 | 37.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 15 | 18 | $5,760 | $1,513 | 26.3% |
| 90853 | Group psychotherapy | Office | 2021 | 13 | 56 | $4,480 | $1,183 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 145 | 604 | $151,000 | $50,875 | 33.7% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session | Office | 2020 | 16 | 456 | $273,600 | $43,424 | 15.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 156 | 640 | $44,800 | $32,930 | 73.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 156 | 478 | $81,260 | $27,184 | 33.5% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 28 | 165 | $23,100 | $12,233 | 53.0% |
About Dr. Daniel Binus, MD
Dr. Daniel Binus, MD is a Psychiatry healthcare provider based in Auburn, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205045028.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Binus, MD has received a total of $7,756 in payments from pharmaceutical and medical device companies, with $1,346 received in 2024. These payments were reported across 377 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($7,652).
As a Medicare-enrolled provider, Binus has provided services to 1,902 Medicare beneficiaries, totaling 8,102 services with total Medicare billing of $576,244. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Auburn, CA
- Active Since 05/21/2007
- Last Updated 12/11/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1205045028
Products in Payments
- VRAYLAR (Drug) $2,728
- REXULTI (Drug) $713.72
- TRINTELLIX (Drug) $382.80
- CAPLYTA (Drug) $378.57
- INGREZZA (Drug) $370.47
- APLENZIN (Drug) $328.98
- AUSTEDO (Drug) $326.88
- ARISTADA (Drug) $300.15
- Azstarys (Drug) $299.67
- Austedo XR (Drug) $265.01
- NEUROSTAR TMS THERAPY SYSTEM (Device) $188.36
- NEUROSTAR TMS THERAPY (Device) $154.15
- ABILIFY MAINTENA (Drug) $141.93
- SPRAVATO (Drug) $131.39
- HETLIOZ (Drug) $125.39
- LOREEV XR (Drug) $114.58
- ABILIFY ASIMTUFII (Drug) $106.97
- ABILIFY MYCITE (Drug) $96.24
- Auvelity (Drug) $85.11
- Dayvigo (Drug) $83.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Auburn
Dr. Adam Nicholas, Md, MD
Psychiatry — Payments: $4,623
Psychiatry $4,623
Aaron Hawkins, M.d, M.D
Psychiatry — Payments: $4,109
Psychiatry $4,109
Abbas Ispahani, Md, MD
Psychiatry — Payments: $2,922
Psychiatry $2,922
Dr. Blair Romer, M.d, M.D
Psychiatry — Payments: $679.18
Psychiatry $679.18
Gene Gomez, Md, MD
Psychiatry — Payments: $501.65
Psychiatry $501.65
Jennifer Smith, Md, MD
Psychiatry — Payments: $386.97
Psychiatry $386.97